Epstein & White Financial’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$418K Buy
3,087
+67
+2% +$9.07K 0.11% 46
2021
Q1
$411K Sell
3,020
-228
-7% -$29.7K 0.12% 42
2020
Q4
$454K Buy
3,248
+1,136
+54% +$159K 0.14% 38
2020
Q3
$294K Sell
2,112
-43
-2% -$5.71K 0.1% 47
2020
Q2
$257K Sell
2,155
-85
-4% -$9.91K 0.1% 60
2020
Q1
$247K Sell
2,240
-1,003
-31% -$120K 0.1% 57
2019
Q4
$405K Sell
3,243
-5,092
-61% -$623K 0.18% 49
2019
Q3
$1.04M Sell
8,335
-360
-4% -$42.5K 0.51% 17
2019
Q2
$926K Buy
8,695
+2,282
+36% +$243K 0.49% 17
2019
Q1
$663K Buy
6,413
+2,700
+73% +$263K 0.38% 25
2018
Q4
$333K Buy
3,713
+48
+1% +$4.29K 0.21% 45
2018
Q3
$296K Sell
3,665
-1,292
-26% -$106K 0.19% 57
2018
Q2
$374K Sell
4,957
-237
-5% -$17.8K 0.28% 61
2018
Q1
$404K Buy
5,194
+227
+5% +$18.9K 0.26% 66
2017
Q4
$432K Buy
+4,967
New +$447K 0.25% 65

Other funds holding PG

Epstein & White Financial's PG Position: Q2 2021 in Review

Epstein & White Financial increased its Procter & Gamble (PG) stake by 2.2% in Q2 2021, buying an estimated $9.07K and bringing the position to 3,087 shares worth $418K. The position accounts for 0.11% of the portfolio, ranked #46.

Epstein & White Financial first reported a position in PG in Q4 2017 and has held it in 15 quarters since. The position peaked at $1.04M in Q3 2019. 2,934 funds tracked by Wall St. Rank hold PG as of Q2 2021.

  • Epstein & White Financial held 3,087 shares of Procter & Gamble worth $418K as of Q2 2021.
  • Epstein & White Financial bought 67 Procter & Gamble shares in Q2 2021, an estimated $9.07K.
  • Procter & Gamble made up 0.11% of Epstein & White Financial's portfolio in Q2 2021, its #46 holding.
  • Epstein & White Financial first reported a position in Procter & Gamble in Q4 2017 and has held it in 15 quarters since.
  • Epstein & White Financial's Procter & Gamble position peaked at $1.04M in Q3 2019.
  • 2,934 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2021.

Based on Epstein & White Financial's 13F filing for Q2 2021, filed 10 Aug 2021.